VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASCO 2020 | Highlights in multiple myeloma at ASCO 2020

Suzanne Lentzsch • 29 May 2020
ASCO 2020
Multiple Myeloma
BOSTON GMMG-CONCEPT KarMMa StaMINA SWOG 1211

Suzanne Lentzsch, MD, PhD, Columbia University, New York, NY, USA, takes us through a selection of the most important studies presented at ASCO 2020 in multiple myeloma. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Suzanne Lentzsch

11:29
Progression and treatment of MGUS-SMM-MM & epigenetics
Elisabet Manasanch et al. • 7 Sep 2018
2:38
How to treat AL amyloidosis in 2020?
Suzanne Lentzsch • 31 Aug 2020
2:50
Unmet needs in amyloidosis
Suzanne Lentzsch • 1 Sep 2020
2:55
Chemotherapy-free approaches to AL amyloidosis
Suzanne Lentzsch • 27 Aug 2020

Related Videos

3:15
Addition of daratumumab to R/R myeloma regimens improves outcomes
Saad Usmani • 18 Dec 2020
2:55
Bispecific antibodies for myeloma: highlights from ASH 2020
Saad Usmani • 17 Dec 2020
1:33
Ide-cel CAR T-cell therapy in newly diagnosed high-risk myeloma
Saad Usmani • 17 Dec 2020
3:22
Anti-BCMA CAR T-cell therapy in myeloma: updates from ASH 2020
Saad Usmani • 17 Dec 2020
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals